2-(4,5-Dimethoxy-2-(((4-(trifluoromethyl)phenyl)amino)sulfonyl)phenyl)acetic acid, 95%, 2g

1-Chloro-1,3-dihydro-3,3-dimethyl-1,2-benziodioxole, 95.0%, 10g

Copper(II) acetate monohydrate, min. 99%, pa, ACS, 250 g, plastic packaging.

2-Bromo-5-ethoxypyridine, 95.0%, 10g

2-(2-Methylphenyl)-4-phenylthiazole, 1g

Ethyl 2-(1-Benzylpiperidin-4-ylidene)acetate, 97.0%, 10g

2-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)ethanone, 95.0%, 1g

4-(Chloromethyl)-2-phenyloxazole, 95.0%, 250mg

Tert-butyl 2-amino-2-cyclopropylacetate, 95%, 5g

2-Cyclopentylpropanoic acid, 98+%, 500mg

1-((2R,4S,5R)-4-((tert-Butyldimethylsilyl)oxy)-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione, 97.0%, 250mg

(5-Amino-1,3-dioxo-1,3-dihydro-isoindol-2-yl)-acetic acid, 100mg

2-(3,4-Dichlorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 5g